METROLOTION Reviews (METRONIDAZOLE)

Average Rating: 3.0 (2 Ratings)

Filter Results

Compare METROLOTION with similar:

 Type: Rx Drug

  

METROLOTION  (METRONIDAZOLE):  This medication is used on the skin to treat a certain skin disorder known as rosacea, a type of adult acne. It may help to decrease redness, swelling and the number of pimples caused by rosacea. This medication is an antibiotic. For the treatment of rosacea, metronidazole is believed to work by decreasing swelling (inflammation). Some brands of this medication also contain sunscreens (see also Notes section).   FDA Approval Date: 1998-11-24 (Sources: U.S. Centers for Medicare Services, FDA)

  

Results are sorted by Date added.

Key to Ratings: 1=LOW (I would not recommend taking this medicine.)
5=HIGH (this medicine cured me or helped me a great deal.)

Page: 1


RATING  REASONSIDE EFFECTS FOR METROLOTIONCOMMENTSSEXAGEDURATION/
DOSAGE
DATE ADDED
 
 1  rosacea none - yet? according to the package insert metronidazole causes cancer in mice and rats but not hamsters. I'd rather have rosacea than cancer. (I was taking the gel version of this drug.) F 36 5 days
3/22/2006
 5  Rosacea None! I am so happy that I finally found a dermatologist smart enough to put me on metrolotion. I am incredibly fair-skinned and for several years I had been getting very red, very hot cheeks at some point during almost every day and didn't know why...when I started applying metrolotion twice a day my symptoms disappeared almost immediately. I definitely notice, too, when I skip a dose. F 26 3 years
7/13/2005
  

METROLOTION  (METRONIDAZOLE):  This medication is used on the skin to treat a certain skin disorder known as rosacea, a type of adult acne. It may help to decrease redness, swelling and the number of pimples caused by rosacea. This medication is an antibiotic. For the treatment of rosacea, metronidazole is believed to work by decreasing swelling (inflammation). Some brands of this medication also contain sunscreens (see also Notes section).   FDA Approval Date: 1998-11-24 (Sources: U.S. Centers for Medicare Services, FDA)

     

BACK TO TOP